• EVIR Therapeutics SA

    VD
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-550.1.192.874-8
    Sector: Production of pharmaceutical substances

    Age of the company

    4 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    190'000

    Employees

    PremiumPremium

    Active brands

    0
    c/o NanoDimension S.A.
    Bâtiment EPFL Innovation Park F
    1015 Lausanne
    Neighbourhood

    Reports for EVIR Therapeutics SA

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About EVIR Therapeutics SA

    • EVIR Therapeutics SA is active in the industry «Production of pharmaceutical substances» and is currently active. The legal headquarters are in Lausanne.
    • The management has 2 active persons registered.
    • On the 28.02.2025 the commercial register entry of the company was last changed. Under «Notifications» you will find all changes.
    • The reported UID is CHE-385.333.233.
    • On the same address as EVIR Therapeutics SA there are 2 other active companies registered. These include: NistronTech Sàrl, OSASUNA Therapeutics SA.

    Commercial register information

    Source: SOGC

    Sector

    Production of pharmaceutical substances

    Purpose (Original language)

    La société a pour but le développement, la fabrication, la production et la commercialisation de vaccins à cellules dendritiques modifiées pour l'immunothérapie des cancers (pour but complet cf. statuts).

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    FORVIS MAZARS SA
    Lausanne 25.11.2022

    Would you like to adjust the auditors? Click here.

    Other company names

    Source: SOGC

    Past and translated company names

    • EVIR Therapeutics Ltd
    • EVIR Therapeutics AG
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: EVIR Therapeutics SA

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250228/2025 - 28.02.2025
    Categories: Change in management

    Publication number: HR02-1006270635, Commercial Registry Office Vaud, (550)

    EVIR Therapeutics SA, à Ecublens (VD), CHE-385.333.233 (FOSC du 05.12.2024, p. 0/1006196294). Kaloulis Konstantinos est nommé administrateur président.

    SOGC 241205/2024 - 05.12.2024
    Categories: Change in management

    Publication number: HR02-1006196294, Commercial Registry Office Vaud, (550)

    EVIR Therapeutics SA, à Ecublens (VD), CHE-385.333.233 (FOSC du 25.11.2022, p. 0/1005613369). Bach González Daniel n'est plus administrateur;
    sa signature est radiée. Kaloulis Konstantinos signe désormais individuellement. Moessinger Eric, des USA, à Pacifica (USA), est membre du conseil d'administration avec signature individuelle.

    SOGC 221125/2022 - 25.11.2022
    Categories: Change of auditors

    Publication number: HR02-1005613369, Commercial Registry Office Vaud, (550)

    EVIR Therapeutics SA, à Ecublens (VD), CHE-385.333.233 (FOSC du 25.11.2020, p. 0/1005031664). Radiation de la mention relative à la renonciation à l'organe de révision.

    Nouvel organe de révision:
    MAZARS SA (CHE-281.111.934), à Lausanne.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm